Acute Myeloid Leukemia (AML) : News

Healthline's Premium Tools

Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
... she had no desire to ever run another one. That all changed in May, when her mother-in-law, Lee, was diagnosed with Acute Myeloid Leukemia (AML). "The same week the packet came in the mail for the marathon was the same week Lee was diagnosed," she ...
Source:Pepperell Free Press
Date:September 26, 2008
... a first-in-class pan Bcl-2 inhibitor. Obatoclax is currently in Phase 2 clinical trials for the treatment of elderly acute myeloid leukemia and the treatment of small cell lung cancer. " This key patent is core to our overall IP strategy and ...
Source:Business Wire
Date:September 23, 2008
The difficulties faced in management and treatment of leukemias are magnified when discussing acute myeloid leukemia .
Source:Advance For Med Lab Pros
Date:September 22, 2008
... in several model systems, including neuronal and hematopoietic cells. We demonstrated that CREB is overexpressed in acute myeloid and leukemia cells compared to normal hematopoietic stem cells. CREB knockdown inhibits leukemic cell proliferation in ...
Source:BMC Cancer
Date:September 18, 2008
... study is designed as a protocol amendment expanding the ongoing Phase 2 trial of sapacitabine in elderly patients with acute myeloid leukemia (AML) to include a cohort of patients with MDS. MDS are a group of hematologic cancers in which the bone ...
Source:MediLexicon
Date:September 15, 2008
Main Category: Lymphoma / Leukemia Also Included In: Blood / Hematology ; Clinical Trials / Drug Trials ; Seniors / Aging Article Date: 15 Sep 2008 - 2:00 PDT Cyclacel Pharmaceuticals, Inc.
Source:Medical News Today
Date:September 15, 2008
Abstract OBJECTIVE: MEIS1, a HOX cofactor, collaborates with multiple HOX and NUP98-HOX fusion proteins to accelerate the onset of acute myeloid leukemia through largely unknown molecular mechanisms.
Source:CiteULike
Date:September 11, 2008
... benefit other families in Sarnia/Lambton County, as that is... Emilie's Legacy In 2004, Emilie was diagnosed with myeloid dysplastic syndrome, MDS, a rare cancer. However, complicating the matter was the fact that Emilie had an abnormal chromosome ...
Source:Sarnia This Week
Date:September 9, 2008
... team involved in the clinical trial of LOR-2040 and high dose cytarabine for treatment of refractory and relapsed acute myeloid leukemia under the overall direction of Dr. Guido Marcucci as Principal Investigator and Dr. Kenneth Chan, Co-Director of ...
Source:Market Wire
Date:September 9, 2008
Celator Pharmaceuticals today announced that the U.S. Food & Drug Administration has granted orphan drug designation to CPX-351 Liposome Injection for the treatment of Acute Myeloid Leukemia .
Source:BioSpace
Date:September 5, 2008
Abstract The molecular heterogeneity of acute leukemias and other tumors constitutes a major obstacle towards understanding disease pathogenesis and developing new targeted-therapies. Aberrant gene regulation ...
Source:CiteULike
Date:July 6, 2008
Advertisement
Back to Top